Robert Essner
Director at Organon & Co. (OGN)
Robert Essner has filed 7 insider reports with the SEC since June 2021, as director at Organon & Co. (OGN) and director at Amicus Therapeutics, Inc. (FOLD). The latest filing, on June 15, 2026, reports grant or award at Organon & Co. (OGN).
- Filings
- 7
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Robert Essner is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $13.92 | Jun 15, 2026 | |||||
| Director | 31,115 | Jun 14, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 12, 2026OGNSEC Form 4 filed by Director Essner RobertForm 4Grant or award
- Jun 13, 2025OGNSEC Form 4 filed by Director Essner RobertForm 4Grant or award
- Jun 7, 2024OGNSEC Form 4 filed by Director Essner RobertForm 4Grant or award
- Jun 9, 2023OGNSEC Form 4 filed by Essner RobertForm 4Grant or award
- Jun 10, 2022OGNSEC Form 4 filed by Essner RobertForm 4Grant or award
- Jun 10, 2021FOLDSEC Form 4: ESSNER ROBERT was granted 10,115 units of Common Stock, increasing direct ownership by 48% to 31,115 unitsForm 4Grant or award
- Jun 4, 2021OGNSEC Form 4 filed by ESSNER ROBERTForm 4Grant or award
Compare Robert Essner with
- Robert Essner vs Juliana Papa Drinane1 shared
- Robert Essner vs Joseph T. Morrissey Jr.1 shared
- Robert Essner vs Arjona Ferreira Juan Camilo1 shared
- Robert Essner vs Lynette Holzbaur1 shared
- Robert Essner vs Shalini Sharp1 shared
- Robert Essner vs Ramona Sequeira1 shared
Other insiders at the same companies
- Juliana Papa DrinaneOGN
- Joseph T. Morrissey Jr.OGN
- Arjona Ferreira Juan CamiloOGN
- Lynette HolzbaurOGN
- Shalini SharpOGN
- Ramona SequeiraOGN
- Cynthia M PattonOGN
- Philip OzuahOGN
- Deborah R LeoneOGN
- Rochelle B LazarusOGN
- Helene D GayleOGN
- Alan EzekowitzOGN
- Craig A WheelerFOLD
- Margaret G McglynnFOLD
- Burke W WhitmanFOLD
- Glenn SblendorioFOLD
Questions about Robert Essner
- What is Robert Essner's role at Organon & Co.?
- Robert Essner reports to the SEC as director at Organon & Co. (OGN), according to the latest filing on June 15, 2026. Robert Essner has also filed as director at Amicus Therapeutics, Inc. (FOLD).
- How many shares does Robert Essner own?
- After the latest filing that states it, Robert Essner directly owned 31,115 shares of Amicus Therapeutics, Inc. (FOLD). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert Essner bought or sold stock recently?
- No open-market purchases or sales by Robert Essner are on file. The filings report grant or award.
- How do I get alerts when Robert Essner files?
- Follow Robert Essner on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Robert Essner (SEC CIK 0001187297). Totals count each trade once, skipping amendments whose original is on file, from Jun 9, 2021 on. View on SEC EDGAR